HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study

Victor Siefert, Joana V. Bettenhausen, Alicia S. Bicu, Ralf Schmidt, Marvin Willam, Miriam Eckl, Florian Stieler, Michael Ehmann, Daniel Buergy, Jens Fleckenstein, Bettina Beuthien-Baumann, Heinz-Peter Schlemmer, Matthias F. Froelich, Stefan O. Schoenberg, Frank A. Giordano, Judit Boda-Heggemann, Constantin Dreher

Open source

DOI: 10.1186/s13014-026-02856-3
Published: 2026-05-29
Container: Radiation Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13014-026-02856-3,
  title = {HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study},
  author = {Victor Siefert and Joana V. Bettenhausen and Alicia S. Bicu and Ralf Schmidt and Marvin Willam and Miriam Eckl and Florian Stieler and Michael Ehmann and Daniel Buergy and Jens Fleckenstein and Bettina Beuthien-Baumann and Heinz-Peter Schlemmer and Matthias F. Froelich and Stefan O. Schoenberg and Frank A. Giordano and Judit Boda-Heggemann and Constantin Dreher},
  year = {2026},
  journal = {Radiation Oncology},
  doi = {10.1186/s13014-026-02856-3},
  url = {https://doi.org/10.1186/s13014-026-02856-3}
}

RIS

TY  - JOUR
TI  - HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study
AU  - Victor Siefert
AU  - Joana V. Bettenhausen
AU  - Alicia S. Bicu
AU  - Ralf Schmidt
AU  - Marvin Willam
AU  - Miriam Eckl
AU  - Florian Stieler
AU  - Michael Ehmann
AU  - Daniel Buergy
AU  - Jens Fleckenstein
AU  - Bettina Beuthien-Baumann
AU  - Heinz-Peter Schlemmer
AU  - Matthias F. Froelich
AU  - Stefan O. Schoenberg
AU  - Frank A. Giordano
AU  - Judit Boda-Heggemann
AU  - Constantin Dreher
PY  - 2026
JO  - Radiation Oncology
DO  - 10.1186/s13014-026-02856-3
UR  - https://doi.org/10.1186/s13014-026-02856-3
ER  -

APA

Siefert, V., Bettenhausen, J. V., Bicu, A. S., Schmidt, R., Willam, M., Eckl, M., Stieler, F., Ehmann, M., Buergy, D., Fleckenstein, J., Beuthien-Baumann, B., Schlemmer, H., Froelich, M. F., Schoenberg, S. O., Giordano, F. A., Boda-Heggemann, J., & Dreher, C. (2026). HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study. Radiation Oncology. https://doi.org/10.1186/s13014-026-02856-3

Source records

crossref · retrieved 2026-11-10T12:20:18.303Z